Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass and molecular pathway cancer diagnostics


ABSTRACT: We report RNA-sequencing data of 283 blood platelet samples, including 228 tumor-educated platelet (TEP) samples collected from patients with six different malignant tumors (non-small cell lung cancer, colorectal cancer, pancreatic cancer, glioblastoma, breast cancer and hepatobiliary carcinomas). In addition, we report RNA-sequencing data of blood platelets isolated from 55 healthy individuals. This dataset highlights the ability of TEP RNA-based 'liquid biopsies' in patients with several types with cancer, including the ability for pan-cancer, multiclass cancer and companion diagnostics. Blood platelets were isolated from whole blood in purple-cap BD Vacutainers containing EDTA anti-coagulant by standard centrifugation. Total RNA was extracted from the platelet pellet, subjected to cDNA synthesis and SMARTer amplification, fragmented by Covaris shearing, and prepared for sequencing using the Truseq Nano DNA Sample Preparation Kit. Subsequently, pooled sample libraries were sequenced on the Illumina Hiseq 2500 platform. All steps were quality-controlled using Bioanalyzer 2100 with RNA 6000 Picochip, DNA 7500 and DNA High Sensitivity chips measurements. For further downstream analyses, reads were quality-controlled using Trimmomatic, mapped to the human reference genome using STAR, and intron-spanning reads were summarized using HTseq. The processed data includes 285 samples (columns) and 57736 ensemble gene ids (rows). The supplementary data file (TEP_data_matrix.txt) contains the intron-spanning read counts, after data summarization by HTseq.

ORGANISM(S): Homo sapiens

SUBMITTER: Myron Best 

PROVIDER: E-GEOD-68086 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

altmetric image

Publications


Tumor-educated blood platelets (TEPs) are implicated as central players in the systemic and local responses to tumor growth, thereby altering their RNA profile. We determined the diagnostic potential of TEPs by mRNA sequencing of 283 platelet samples. We distinguished 228 patients with localized and metastasized tumors from 55 healthy individuals with 96% accuracy. Across six different tumor types, the location of the primary tumor was correctly identified with 71% accuracy. Also, MET or HER2-po  ...[more]

Similar Datasets

2024-05-31 | E-MTAB-14072 | biostudies-arrayexpress
2014-02-04 | E-GEOD-51453 | biostudies-arrayexpress
2014-07-17 | E-GEOD-59488 | biostudies-arrayexpress
2013-10-01 | E-MTAB-1846 | biostudies-arrayexpress
2015-09-15 | E-GEOD-65705 | biostudies-arrayexpress
2018-01-15 | E-MTAB-6148 | biostudies-arrayexpress
2016-01-14 | E-GEOD-76789 | biostudies-arrayexpress
2012-06-30 | E-MTAB-715 | biostudies-arrayexpress
2008-06-18 | E-GEOD-11524 | biostudies-arrayexpress
2022-07-01 | E-MTAB-9673 | biostudies-arrayexpress